Tammy Furlong's Insider Trades & SAST Disclosures
Tammy Furlong's most recent trade in Elevation Oncology Inc was a trade of 2,643 Common Stock done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Tammy Furlong.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 2,643 | 10,859 | - | - | Common Stock | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 2,343 | 25,782 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.30 per share. | 15 May 2025 | 784 | 10,075 | - | 0.3 | 235 | Common Stock |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 300 | 2,100 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 9,375 | 28,125 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 9,375 | 10,785 | - | - | Common Stock | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 15 Feb 2025 | 2,780 | 8,005 | - | 0.7 | 1,867 | Common Stock |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 300 | 2,400 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 300 | 8,305 | - | - | Common Stock | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 15 Feb 2025 | 89 | 8,216 | - | 0.7 | 60 | Common Stock |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 300 | 1,508 | - | - | Common Stock | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 300 | 2,700 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.53 per share. | 15 Nov 2024 | 98 | 1,410 | - | 0.5 | 52 | Common Stock |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 300 | 1,297 | - | - | Common Stock | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 300 | 3,000 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.72 per share. | 15 Aug 2024 | 89 | 1,208 | - | 0.7 | 64 | Common Stock |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 300 | 3,300 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 300 | 1,097 | - | - | Common Stock | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.73 per share. | 15 May 2024 | 100 | 997 | - | 3.7 | 373 | Common Stock |
| Elevation Oncology Inc | Furlong Tammy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 37,500 | 37,500 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,200 | 1,200 | - | - | Common Stock | |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,200 | 3,600 | - | - | Restricted Stock Unit | |
| Elevation Oncology Inc | Furlong Tammy | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.77 per share. | 15 Feb 2024 | 403 | 797 | - | 2.8 | 1,116 | Common Stock |
| Elevation Oncology Inc | Tammy Furlong | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 53,433 | 53,433 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges